From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Aptamer – CEO “has left… with immediate effect” state the group’s other AIM IPO Roll-Call of Shame directors. And how’s the funding “exploring” going?

By Steve Moore | Wednesday 10 May 2023


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Stating that it develops novel binders to enable new approaches in therapeutics, diagnostics and research applications, Aptamer Group (APTA) has also today announced that “Dr. Arron Tolley has left his position as Chief Executive Officer and Board Director, with immediate effect. He will leave his employment with the group after a period of garden leave… A search for a full-time CEO will begin immediately”. So what’s the circumstances here?
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Wednesday »

Bearcast

Tom Winnifrith Bearcast: Bracing myself

Thursday »

LUCE

Luceco – a trading recovery Buy?...

 

Quiz

The ShareProphets Sunday Pub Quiz #260

Thursday »

TM1

Rat. Sinking Ship. Technology Minerals

Time left: 22:41:25